(Q45062337)

9 December 2017

Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model (English)

1 reference

amyotrophic lateral sclerosis

9 December 2017

1 reference

1 reference

5

Albert C Ludolph

1 reference

9 December 2017

Stefan Waibel

1

1 reference

9 December 2017

Alexander Reuter

series ordinal

2

1 reference

9 December 2017

Susanne Malessa

series ordinal

3

1 reference

9 December 2017

Eran Blaugrund

series ordinal

4

1 reference

9 December 2017

language of work or name

1 reference

1 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

251

1 reference

9 December 2017

9

1 reference

9 December 2017

1080-1084

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-004-0481-5

9 December 2017

0 references

cites work

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

1 reference

12 December 2020

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

1 reference

12 December 2020

Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation.

1 reference

12 December 2020

Antiglutamate therapy of ALS--which is the next step?

1 reference

12 December 2020

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

1 reference

12 December 2020

Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol

1 reference

12 December 2020

Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1

1 reference

12 December 2020

Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat

1 reference

12 December 2020

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

12 December 2020

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

1 reference

12 December 2020

Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

12 December 2020

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

1 reference

12 December 2020

The pharmacology and mechanism of action of riluzole

1 reference

12 December 2020

Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022

1 reference

12 December 2020

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

12 December 2020

Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

10.1007/S00415-004-0481-5

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference